| I. |
|
Introductions |
| |
|
Dr. James Gordon, Chair |
| |
| II. |
|
Welcoming remarks |
| |
|
Peter Reinecke |
| |
|
Legislative Director for Senator Tom Harkin |
| |
| III. |
|
Ethics Review for Federal Advisory Committee Members |
| |
|
Karen Santoro |
| |
|
Ethics Counsel, National Institutes of Health |
| |
| IV. |
|
Review of the Agenda and Charge to the Commission |
| |
|
Dr. Stephen Groft, Executive Director |
| |
| V. |
|
Discussion of Vision, Issues and Concerns of the Commission Members |
| |
| |
|
(A) |
|
Coordinated research to increase knowledge about complementary and alternative medicine practices and products. |
| |
| |
|
(B) |
|
Guidance for appropriate access to and delivery of complementary and alternative medicine. |
| |
| |
|
(C) |
|
The provision to health care professionals of reliable and useful information about complementary and alternative medicine that can be made readily accessible and understandable to the general public. |
| |
| |
|
(D) |
|
The education and training of health care practitioners in complementary and alternative medicine. |
| |
| |
|
(Discussion Will Include Commission Needs and Methods to Obtain Information, Specific Agenda Items and Activities of the Commission Required to Meet the Commission's Mandate) |
| |
| VI. |
|
Public Comment Period (1:00 - 2:00 p.m. July 14, 2000) |
| |
| VII. |
|
Other Activities of the Commission and Staff |
| |
| |
|
1.) |
|
Interactive Website |
| |
| |
|
2.) |
|
Public Meetings/Hearings |
| |
| |
|
3.) |
|
Development of Position Papers |
| |
| VIII. |
|
Future Meeting Dates and Locations |
| |
| IX. |
|
Time Frame for Completion of Report |